Scientech Research LLC’s Boston Scientific BSX Stock Holding History

Scientech Research LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,778	Closed	-$857K	–	537
2025 Q3	$857K	Buy	8,778 +383	+5%	+$39.7K	0.3%	58
2025 Q2	$902K	Buy	8,395 +6,254	+292%	+$633K	0.22%	162
2025 Q1	$216K	Sell	2,141 -1,920	-47%	-$193K	0.06%	486
2024 Q4	$363K	Buy	+4,061	New	+$357K	0.1%	379

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Scientech Research LLC's BSX Position: Q4 2025 in Review

Scientech Research LLC sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 8,778 shares — an estimated $857K sold.

Scientech Research LLC first reported a position in BSX in Q4 2024 and held it in 4 quarters. The position peaked at $902K in Q2 2025. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Scientech Research LLC reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Scientech Research LLC sold 8,778 Boston Scientific shares in Q4 2025, an estimated $857K.
Scientech Research LLC first reported a position in Boston Scientific in Q4 2024 and held it in 4 quarters.
Scientech Research LLC's Boston Scientific position peaked at $902K in Q2 2025.
1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.